<DOC>
	<DOCNO>NCT00599820</DOCNO>
	<brief_summary>Intravitreal Bevacizumab effective treatment choroidal neovascularization secondary Angioid Streaks</brief_summary>
	<brief_title>Use Intravitreal Bevacizumab Eyes With Choroidal Neovascularization Secondary Angioid Streaks</brief_title>
	<detailed_description>A consecutive case series patient angioid streak develop subfoveal choroidal neovascularization treat primary 2.5 mg injection Bevacizumab ( Avastin ) intravitreally . All patient evaluate BCVA 1 , 2 , 4 12 week OCT fluoresceine angiography month 1 3 . ( Patients follow 6 month )</detailed_description>
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<mesh_term>Neovascularization , Pathologic</mesh_term>
	<mesh_term>Angioid Streaks</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Clinical diagnosis Angioid Streaks Choroidal neovascularization associate Untreated patient patient treat PDT Ocular surgery except uncomplicated phacoemulsification Glaucoma ocular pathology</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Angioid Streaks</keyword>
	<keyword>Choroidal Neovascularization</keyword>
	<keyword>Bevacizumab</keyword>
</DOC>